Headline News
ANI Pharmaceuticals shares are trading higher after the company announced FDA approval of Purified Cortrophin Gel for multiple indications including multiple sclerosis, rheumatoid arthritis and nephrotic syndrome.
by | Nov 1, 2021 | Uncategorized | 0 comments

Recent Comments